NM_000546.6(TP53):c.6G>A (p.Glu2=) AND not specified

Germline classification:: Benign (2 submissions)
Last evaluated:: Oct 14, 2021
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000508330.12

Allele description [Variation Report for NM_000546.6(TP53):c.6G>A (p.Glu2=)]

NM_000546.6(TP53):c.6G>A (p.Glu2=)

Gene:

TP53:tumor protein p53 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

17p13.1

Genomic location:

Preferred name:

NM_000546.6(TP53):c.6G>A (p.Glu2=)

HGVS:

NC_000017.11:g.7676589C>T
NG_017013.2:g.15962G>A
NM_000546.6:c.6G>AMANE SELECT
NM_001126112.3:c.6G>A
NM_001126113.3:c.6G>A
NM_001126114.3:c.6G>A
NM_001126118.2:c.-229G>A
NM_001276695.3:c.-112G>A
NM_001276696.3:c.-112G>A
NM_001276760.3:c.-112G>A
NM_001276761.3:c.-112G>A
NP_000537.3:p.Glu2=
NP_000537.3:p.Glu2=
NP_001119584.1:p.Glu2=
NP_001119585.1:p.Glu2=
NP_001119586.1:p.Glu2=
LRG_321t1:c.6G>A
LRG_321:g.15962G>A
LRG_321p1:p.Glu2=
NC_000017.10:g.7579907C>T
NM_000546.4:c.6G>A
NM_000546.5:c.6G>A
p.E2E
p.Glu2Glu

Links:

dbSNP: rs143458271

NCBI 1000 Genomes Browser:

rs143458271

Molecular consequence:

NM_001126118.2:c.-229G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001276695.3:c.-112G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001276696.3:c.-112G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001276760.3:c.-112G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001276761.3:c.-112G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000546.6:c.6G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001126112.3:c.6G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001126113.3:c.6G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001126114.3:c.6G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000602276	Quest Diagnostics Nichols Institute San Juan Capistrano	criteria provided, single submitter (Quest Diagnostics criteria)	Benign (Mar 30, 2017)	germline	clinical testing	PubMed (2) [See all records that cite these PMIDs] 18348286, 26467025
SCV001338226	Women's Health and Genetics/Laboratory Corporation of America, LabCorp	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015)	Benign (Oct 14, 2021)	germline	clinical testing	PubMed (19) [See all records that cite these PMIDs] 17606709, 21343334, 20407015, 26230955, 21519010, 27463065, 25952993, 22186996, 27680515, 27959731, 16818505, 27895058, 30327374, 11782540, 23246812, 22915647, 26585234, 27276561, 24336192 Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000602276

Quest Diagnostics Nichols Institute San Juan Capistrano

criteria provided, single submitter

(Quest Diagnostics criteria)

Benign
(Mar 30, 2017)

germline

clinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001338226

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)

Benign
(Oct 14, 2021)

germline

clinical testing

PubMed (19)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation calling.

Bastien R, Lewis TB, Hawkes JE, Quackenbush JF, Robbins TC, Palazzo J, Perou CM, Bernard PS.

Hum Mutat. 2008 May;29(5):757-64. doi: 10.1002/humu.20726.

PubMed [citation]

PMID:: 18348286

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]

PMID:: 26467025
PMCID:: PMC4737317

See all PubMed Citations (21)

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV000602276.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (2)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001338226.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (19)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine